Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results
Vanda Pharmaceuticals Inc announced it will release results for the fourth quarter of 2016 on Wednesday, February 15, 2017, after...
Vanda Pharmaceuticals Inc announced it will release results for the fourth quarter of 2016 on Wednesday, February 15, 2017, after...
Eli Lilly and Company and CoLucid Pharmaceuticals announced an agreement for Lilly to acquire CoLucid for $46.50 per share or...
Irvine Scientific, a worldwide leader in cell culture media development and manufacturing announced the introduction of PRIME-XV T Cell CDM,...
Swedish-based digital health company AMRA has announced a $9 million funding round co-led by US-based Pfizer Venture Investments and leading...
The agreement will benefit clinical trials, delivering Suvoda’s cutting edge IRT/IWRS technology for subject randomization and trial supply management integrated...
The store has been introduced to provide customers with easy access to research quantities of commercial grade ligands and catalysts,...
ARIAD Pharma announced it has entered into a definitive agreement to be acquired by Takeda Pharmaceutical Company Limited under which...
The COPD Foundation-sponsored COPD Biomarker Qualification Consortium announced that it has partnered with the Bio Techne Cor, a manufacturer of...
Aerie Pharmaceuticals Inc,a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of...
Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.